11th Alzheimer’s & Parkinson’s Drug Development


11th Alzheimer’s & Parkinson’s Drug Development

Programme du congrès

Lieu : San Francisco

Pays : Etats-Unis

Langue : ENG

Date de début :

Date de fin :

Spécialités : Gériatrie , Neurologie

11th Alzheimer’s & Parkinson’s Drug Development: What to Expect in 2023!
Heading to sunny San Francisco for the first time, the 11th Alzheimer’s & Parkinson’s Drug Development Summit is the only-industry-focused event dedicated to overcoming the challenges and showcasing the opportunities of targeting Alzheimer’s and Parkinson’s Disease.
Previously known as the Neurodegenerative Drug Development Summit, don’t miss your only opportunity to hear about the latest clinical pipeline progressions in 2022, learn new insights into neurodegenerative disease mechanisms for new target identification, explore the latest advances in neurological biomarkers and how to incorporate them into clinical trials successfully, and discover the next generation in-vitro and in-vivo preclinical models for safety and efficacy testing.

Toutes les vidéos du congrès ( 0 vidéos )

Suggérer une vidéo

Sélection de congrès